Prescription drug · ANDA
Doxercalciferol NDC 70518-4642
Doxercalciferol .5 ug/1 · Capsule · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4642-0 | 70518464200 | 50 POUCH in 1 BOX (70518-4642-0) / 1 CAPSULE in 1 POUCH (70518-4642-1)Marketed from Apr 28, 2026 | |
| 70518-4642-2 | 70518464202 | 100 POUCH in 1 BOX (70518-4642-2) / 1 CAPSULE in 1 POUCH (70518-4642-1)Marketed from Jul 17, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxercalciferol
- Generic name (nonproprietary)
- doxercalciferol
- Active ingredients
- Doxercalciferol — .5 ug/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- REMEDYREPACK INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205360
- Marketing start
- Listing expires
- Other FDA classes
- Ergocalciferols (Chemical structure)
- Identifiers
- Product ID 70518-4642_56cdf5b4-26a5-4046-e063-6294a90ab84dSPL ID 56cdf5b4-26a5-4046-e063-6294a90ab84dSPL set ID 943a3f95-842c-455f-9050-3d1c3971c6f8RxCUI 406503UNII 3DIZ9LF5Y9
- Pharmacologic class
- Vitamin D2 Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518464200followed by a unit qualifier and the quantityPackage 70518-4642-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis. Doxercalciferol Capsules is a synthetic vitamin D 2 analog: Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 205360
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxercalciferol | Doxercalciferol 1 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-539 |
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-538 |
| Doxercalciferol | Doxercalciferol 2.5 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-540 |
| Doxercalciferol | Doxercalciferol 1 ug/1 | CapsuleOral | Chartwell RX, LLC | 62135-451 |
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | Chartwell RX, LLC | 62135-450 |
| Doxercalciferol | Doxercalciferol 2.5 ug/1 | CapsuleOral | Chartwell RX, LLC | 62135-452 |